Assurant (AIZ)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-05
$306.87-0.53%
Close 2026-11-05 · 1-day change
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-05
Research Workspace
Put AIZ beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on earnings delivery.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAIZ's EBITDA growth engine has to keep compounding to justify the price. Revenue grew 9% year over year in the last reported quarter. The company beat its Q3 earnings estimate by 34.6%. It trades at 2.5 times book value versus a 1.3 times peer median. The price reflects less growth than we forecast. Management is running behind on a stated commitment. Peer multiples imply a price roughly in line with where it trades (about fair). The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-05. AIZ is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 7 analysts currently covering AIZ (as of Nov 2026).
Based on 5 Wall Street analysts offering 12-month price targets for AIZ in the last 4 months.
Continue this research
Compare AIZ with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AIZ Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Multi-line Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put AIZ next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase Adjusted EBITDA and Adjusted EPS excluding catastrophes
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-05. EPS is implied from price ÷ P/E. Not investment advice.
Current $306.87
The last 12 months of price, then the range of analyst 12-month targets from today’s $306.87.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Confirms EBITDA growth target and increased buybacks.
Advances: Increase Adjusted EBITDA and Adjusted EPS excluding catastrophes
Double-digit growth supports record year and EBITDA goals.
Advances: Maintain disciplined capital deployment with share repurchases and dividends
Dividend hike supports disciplined capital deployment objective.
Advances: Increase Adjusted EBITDA and Adjusted EPS excluding catastrophes
Signals growth in adjusted EBITDA and EPS aligns with objectives.
Advances: Increase Adjusted EBITDA and EPS
Sales beat indicates strong growth potential for Adjusted EBITDA.
Advances: Enhance Global Lifestyle EBITDA
Positive outlook on Global Lifestyle earnings.
Advances: Increase Adjusted EBITDA and EPS
Upgrade indicates positive growth outlook.
Advances: Enhance Global Housing EBITDA
New product enhances Global Housing offerings.
